ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 42 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | -95.3% | 5,000 | -96.0% | 0.00% | -100.0% |
| Q4 2019 | $43,000 | -12.2% | 126,500 | -11.2% | 0.00% | 0.0% |
| Q3 2019 | $49,000 | 0.0% | 142,500 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $49,000 | -15.5% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $58,000 | +1.8% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $57,000 | -50.0% | 142,500 | -0.3% | 0.00% | -50.0% |
| Q3 2018 | $114,000 | +18.8% | 143,000 | +18.7% | 0.00% | -20.0% |
| Q2 2018 | $96,000 | – | 120,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |